Azmet-VG 2mg/500mg/0.2mg Tablet SR
Marketer
Azkka Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Azmet-VG 2mg/500mg/0.2mg Tablet SR
Diabetace-Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic agents. This combination medication treats type 2 diabetes in adults by helping regulate blood glucose. Diabetace-Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.
Uses of Azmet-VG 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Azmet-VG 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Azmet-VG 2mg/500mg/0.2mg Sustained-Release Tablets on an empty stomach.
Common Side effects of Azmet-VG 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Azmet-VG 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Azmet-VG 2mg/500mg/0.2mg SR tablet whole; do not crush, chew, or break it. Administer this medication on an empty stomach.
How Azmet-VG 2mg/500mg/0.2mg Tablet SR works:
Azmet-VG SR tablets (2mg/500mg/0.2mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Azmet-VG 2mg/500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Azmet-VG 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Azmet-VG tablets (2mg/500mg/0.2mg) are likely unsuitable for breastfeeding mothers. Available human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms manifest.
KidneyUNSAFE
Employing Azmet-VG 2mg/500mg/0.2mg Tablet SR carries a high likelihood of risk for individuals with impaired kidney function and is best omitted. Medical advice is recommended. Furthermore, this medication is unsuitable for patients exhibiting severely compromised kidney health.
LiverCAUTION
Patients with liver impairment should use Azmet-VG 2mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Azmet-VG 2mg/500mg/0.2mg Tablet SR is typically initiated at a low dose; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Azmet-VG 2mg/500mg/0.2mg Tablet SR :
Should you forget to take your Azmet-VG 2mg/500mg/0.2mg Tablet SR, administer it promptly. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Azmet-VG 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently